Cargando…
Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer
BACKGROUND: Serum levels of the extracellular domain of HER2/neu (HER2 ECD) have been demonstrated to be associated with clinical outcomes. A disintegrin and metalloproteinase-10, a sheddase of HER2/neu, can drive cancer progression and its activity is inhibited by tissue inhibitor of metalloprotein...
Autores principales: | Tsai, Hsiu-Pei, Chen, Shin-Cheh, Chien, Huei-Tzu, Jan, Yi-Yin, Chao, Tzu-Chieh, Chen, Miin-Fu, Hsieh, Ling-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312842/ https://www.ncbi.nlm.nih.gov/pubmed/22339939 http://dx.doi.org/10.1186/1477-7819-10-42 |
Ejemplares similares
-
Differential microRNA expression in breast cancer with different onset age
por: Tsai, Hsiu-Pei, et al.
Publicado: (2018) -
Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer
por: Lam, Lian, et al.
Publicado: (2014) -
Direct Determination of ECD in ECD Kit: A Solid Sample Quantitation Method for Active Pharmaceutical Ingredient in Drug Product
por: Chao, Ming-Yu, et al.
Publicado: (2011) -
Analysis of iodine content in seaweed by GC-ECD and estimation of iodine intake
por: Yeh, Tai Sheng, et al.
Publicado: (2014) -
Internet-Delivered Cognitive Behavior Therapy for Young Taiwanese Female Nursing Students with Irritable Bowel Syndrome—A Cluster Randomized Controlled Trial
por: Lee, Tzu-Ying, et al.
Publicado: (2019)